Short- and long-term stability study of lyophilized solid lipid nanoparticles for gene therapy

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 71, Issue 2, 2009, Pages 181-189

  del Pozo Rodriguez A ^a   Solinis M A ^a   Gascon A R ^a   Pedraz, J L ^a  

^a UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

Author keywords

Gene therapy; Lyophilization; Non viral vectors; Solid lipid nanoparticles; Stability study

Indexed keywords

1,2 DIOLEOYL 3 TRIMETHYLAMMONIOPROPANE; DISACCHARIDE; DODECYL SULFATE SODIUM; ENHANCED GREEN FLUORESCENT PROTEIN; GLYCEROL PALMITOSTEARATE; LIPOPLEX; POLYSORBATE 80; SOLID LIPID NANOPARTICLE; TREHALOSE;

ARTICLE; CELL VIABILITY; CONTROLLED STUDY; DNA VECTOR; DRUG FORMULATION; DRUG STABILITY; FREEZE DRYING; GENE THERAPY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMIDITY; PARTICLE SIZE; PLASMID; POLYMERIZATION; STORAGE TEMPERATURE;

CELL LINE; CELL SURVIVAL; DRUG STABILITY; DRUG STORAGE; FREEZE DRYING; GENE THERAPY; GENETIC VECTORS; HUMANS; HUMIDITY; LIPIDS; NANOPARTICLES; PARTICLE SIZE; PLASMIDS; TEMPERATURE; TIME FACTORS; TRANSFECTION; TREHALOSE;

EID: 59649111692     PISSN: 09396411     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejpb.2008.09.015     Document Type: Article

References (47)

1. Jackson D.A., Juranek S., and Lipps H.J. Designing nonviral vectors for efficient gene transfer and long-term gene expression. Mol. Ther. 14 (2006) 613-626
2. Odom G.L., Gregorevic P., and Chamberlain J.S. Viral-mediated gene therapy for the muscular dystrophies: successes, limitations and recent advances. Biochim. Biophys. Acta 1772 (2007) 243-262
3. van der Wouden E.A., Sandovici M., Henning R.H., de Zeeuw D., and Deelman L.E. Approaches and methods in gene therapy for kidney disease. J. Pharmacol. Toxicol. Meth. 50 (2004) 13-24
4. del Pozo-Rodríguez A., Delgado D., Solinís M.A., Gascón A.R., and Pedraz J.L. Solid lipid nanoparticles: formulation factors affecting cell transfection capacity. Int. J. Pharm. 339 (2007) 261-268
5. del Pozo-Rodríguez A., Delgado D., Solinís M.A., Gascón A.R., and Pedraz J.L. Solid lipid nanoparticles for retinal gene therapy: transfection and intracellular trafficking in RPE cells. Int. J. Pharm. 360 (2008) 177-183
6. Olbrich C., Bakowsky U., Lehr C.M., Muller R.H., and Kneuer C. Cationic solid-lipid nanoparticles can efficiently bind and transfect plasmid DNA. J. Control. Release 77 (2001) 345-355
7. Anchordoquy T.J., and Koe G.S. Physical stability of nonviral plasmid-based therapeutics. J. Pharm. Sci. 89 (2000) 289-296
8. Caplen N.J., Alton E.W.F.W., Middleton P.G., Dorin J.R., Stevenson B.J., Gao X., Durham S.R., Jeffery P.K., Hodson M.E., Coutelle C., Huang L., Porteous D.J., Williamson R., and Geddes D.M. Liposome-mediated Cftr gene-transfer to the nasal epithelium of patients with cystic-fibrosis. Nat. Med. 1 (1995) 39-46
9. Nabel G.J., Nabel E.G., Yang Z.Y., Fox B.A., Plautz G.E., Gao X., Huang L., Shu S.Y., Gordon D., and Chang A.E. Direct gene-transfer with DNA liposome complexes in melanoma - expression, biologic activity, and lack of toxicity in humans. Proc. Natl. Acad. Sci. USA 90 (1993) 11307-11311
10. Anchordoquy T.J., Girouard L.G., Carpenter J.F., and Kroll D.J. Stability of lipid/DNA complexes during agitation and freeze-thawing. J. Pharm. Sci. 87 (1998) 1046-1051
11. Cherng J.-Y., Wetering P., Talsma H., Crommelin D.J.A., and Hennink W.E. Stabilization of polymer-based gene delivery systems. Int. J. Pharm. 183 (1999) 25-28
12. Hinrichs W.L.J., Mancenido F.A., Sanders N.N., Braeckmans K., De Smedt S.C., Demeester J., and Frijlink H.W. The choice of a suitable oligosaccharide to prevent aggregation of PEGylated nanoparticles during freeze thawing and freeze drying. Int. J. Pharm. 311 (2006) 237-244
13. Allison S.D., Molina M., and Anchordoquy T.J. Stabilization of lipid/DNA complexes during the freezing step of the lyophilization process: the particle isolation hypothesis. Biochim. Biophys. Acta 1468 (2000) 127-138
14. Anchordoquy T.J., Carpenter J.F., and Kroll D.J. Maintenance of transfection rates and physical characterization of lipid/DNA complexes after freeze-drying and rehydration. Arch. Biochem. Biophys. 348 (1997) 199-206
15. Brus C., Kleemann E., Aigner A., Czubayko F., and Kissel T. Stabilization of oligonucleotide-polyethylenimine complexes by freeze-drying: physicochemical and biological characterization. J. Control. Release 95 (2004) 119-131
16. Li B., Li S., Tan Y.D., Stolz D.B., Watkins S.C., Block L.H., and Huang L. Lyophilization of cationic lipid-protamine-DNA (LPD) complexes. J. Pharm. Sci. 89 (2000) 355-364
17. Zhong Z.R., Zhang Z.R., Liu J., Deng Y., Zhang H.W., Fu Y., Song Q.G., and He Q. Characteristics comparison before and after lyophilization of transferrin modified procationic-liposome-protamine-DNA complexes (Tf-PLPD). Arch. Pharm. Res. 30 (2007) 102-108
18. Allison S.D., and Anchordoquy T.J. Mechanisms of protection of cationic lipid-DNA complexes during lyophilization. J. Pharm. Sci. 89 (2000) 682-691
19. Hinrichs W.L.J., Sanders N.N., De Smedt S.C., Demeester J., and Frijlink H.W. Inulin is a promising cryo- and lyo-protectant for PEGylated lipoplexes. J. Control. Release 103 (2005) 465-479
20. Schwarz C., and Mehnert W. Freeze-drying of drug-free and drug-loaded solid lipid nanoparticles (SLN). Int. J. Pharm. 157 (1997) 171-179
21. Zimmermann E., Muller R.H., and Mader K. Influence of different parameters on reconstitution of lyophilized SLN. Int. J. Pharm. 196 (2000) 211-213
22. ™) dispersions. Int. J. Pharm. 168 (1998) 221-229
23. Luo Y., Chen D., Ren L., Zhao X., and Qin J. Solid lipid nanoparticles for enhancing vinpocetine's oral bioavailability. J. Control. Release 114 (2006) 53-59
24. Saupe A., Gordon K.C., and Rades T. Structural investigations on nanoemulsions, solid lipid nanoparticles and nanostructured lipid carriers by cryo-field emission scanning electron microscopy and Raman spectroscopy. Int. J. Pharm. 314 (2006) 56-62
25. Maitani Y., Aso Y., Yamada A., and Yoshioka S. Effect of sugars on storage stability of lyophilized liposome/DNA complexes with high transfection efficiency. Int. J. Pharm. 356 (2008) 69-75
26. Molina M., and Anchordoquy T.J. Degradation of lyophilized lipid/DNA complexes during storage: the role of lipid and reactive oxygen species. Biochim. Biophys. Acta. 1778 (2008) 2119-2126
27. Mehnert W., and Mader K. Solid lipid nanoparticles - production, characterization and applications. Adv. Drug Deliv. Rev. 47 (2001) 165-196
28. Nanassy O.Z., Haydock P.V., and Reed M.W. Capture of genomic DNA on glass microscope slides. Anal. Biochem. 365 (2007) 240-245
29. Vogelstein B., and Gillespie D. Preparative and analytical purification of DNA from Agarose. Proc. Natl. Acad. Sci. USA 76 (1979) 615-619
30. Gustafsson J., Arvidson G., Karlsson G., and Almgren M. Complexes between cationic liposomes and DNA visualized by cryo-tem. Biochim. Biophys. Acta 1235 (1995) 305-312
31. Mahato R.I. Non-viral peptide-based approaches to gene delivery. J. Drug Target. 7 (1999) 249-268
32. Tang M.X., and Szoka F.C. The influence of polymer structure on the interactions of cationic polymers with DNA and morphology of the resulting complexes. Gene Ther. 4 (1997) 823-832
33. Molina M.D.C., Allison S.D., and Anchordoquy T.J. Maintenance of nonviral vector particle size during the freezing step of the lyophilization process is insufficient for preservation of activity: insight from other structural indicators. J. Pharm. Sci. 90 (2001) 1445-1455
34. Poxon S.W., and Hughes J.A. The effect of lyophilization on plasmid DNA activity. Pharm. Dev. Technol. 5 (2000) 115-122
35. Cavalli R., Caputo O., Carlotti M.E., Trotta M., Scarnecchia C., and Gasco M.R. Sterilization and freeze-drying of drug-free and drug-loaded solid lipid nanoparticles. Int. J. Pharm. 148 (1997) 47-54
36. Heiati H., Tawashi R., and Phillips N.C. Drug retention and stability of solid lipid nanoparticles containing azidothymidine palmitate after autoclaving, storage and lyophilization. J. Microencapsul. 15 (1998) 173-184
37. Hinrichs W.L.J., Prinsen M.G., and Frijlink H.W. Inulin glasses for the stabilization of therapeutic proteins. Int. J. Pharm. 215 (2001) 163-174
38. Molina M.D., Armstrong T.K., Zhang Y., Patel M.M., Lentz Y.K., and Anchordoquy T.J. The stability of lyophilized lipid/DNA complexes during prolonged storage. J. Pharm. Sci. 93 (2004) 2259-2273
39. Crowe J.H., and Crowe L.M. Preserving dry biomaterials: the water replacement hypothesis. Part 1. Biopharmaceutics 6 (1993) 28-37
40. Crowe J.H., and Crowe L.M. Preserving dry biomaterials: the water replacement hypothesis. Part 2. Biopharmaceutics 6 (1993) 40-43
41. Middaugh C.R., Evans R.K., Montgomery D.L., and Casimiro D.R. Analysis of plasmid DNA from a pharmaceutical perspective. J. Pharm. Sci. 87 (1998) 130-146
42. Remaut K., Sanders N.N., Fayazpour F., Demeester J., and De Smedt S.C. Influence of plasmid DNA topology on the transfection properties of dotap/dope lipoplexes. J. Control. Release 115 (2006) 335-343
43. Seville P.C., Kellaway I.W., and Birchall J.C. Preparation of dry powder dispersions for non-viral gene delivery by freeze-drying and spray-drying. J. Gene Med. 4 (2002) 428-437
44. Kawakami S., Higuchi Y., and Hashida M. Nonviral approaches for targeted delivery of plasmid DNA and oligonucleotide. J. Pharm. Sci. 97 (2008) 726-745
45. Delie F. Evaluation of nano- and microparticle uptake by the gastrointestinal tract. Adv. Drug Deliv. Rev. 34 (1998) 221-233
46. Schiffelers R.M., de Wolf H.K., van Rooy I., and Storm G. Synthetic delivery systems for intravenous administration of nucleic acids. Nanomedicine 2 (2007) 169-181
47. Hancock B.C., Shamblin S.L., and Zografi G. Molecular mobility of amorphous pharmaceutical solids below their glass-transition temperatures. Pharm. Res. 12 (1995) 799-806